查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1844153

疼痛管理设备市场（按设备类型、应用程式、分销管道、最终用户和购买方式划分）—2025-2032年全球预测

Pain Management Devices Market by Device Type, Application, Distribution Channel, End User, Mode of Purchase - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，疼痛管理设备市场规模将达到 73.2 亿美元，复合年增长率为 9.06%。

主要市场统计数据
基准年 2024 36.5亿美元
预计年份：2025年 39.7亿美元
预测年份：2032年 73.2亿美元
复合年增长率 (%) 9.06%

清晰的策略方向，为塑造现代疼痛管理器材策略的不断变化的临床、商业和法规环境奠定基础。

本执行摘要首先为复杂且快速发展的疼痛管理设备领域提供循证指导，阐明了报告的目标及其为临床、商业和政策相关人员带来的价值。

引言部分重点阐述并分析了影响产品开发和应用的各种因素，包括向非阿片类药物治疗策略的转变、门诊和居家照护模式的兴起，以及数位健康功能与设备平台的日益融合。这些动态正在重塑临床管道，并影响医生、医院管理者和支付方的决策标准。鑑于临床偏好和以患者为中心的护理趋势的变化，设备製造商和服务供应商必须重新审视产品系列、市场推广模式和合作伙伴关係。

本节概述了报告的分析框架和整合的证据类型，重点阐述了监管考虑、报销压力、供应链韧性和技术融合如何影响后续的分析结果。引言围绕着安全性、有效性、易用性和整合性提出关键问题，为读者提供了一个实用的视角，以便他们解读后续章节，并将研究结果应用于产品策略、市场推广计画和投资评估。

临床偏好的改变、医疗服务的分散化、数位化整合以及监管期望的演变，正在重新定义疼痛管理设备的产品和商业策略。

疼痛管理设备领域正在经历多项变革时期，这些变革正在改变临床工作流程、产品生命週期和商业性重点。

首先，随着临床医生寻求持久有效的非药物治疗方法以减少对全身性止痛药物的依赖，神经调控和微创治疗已成为治疗领域的一大趋势。这一趋势推动了对电刺激、射频技术和磁疗的研究，这些技术能够靶向特定的疼痛通路，同时保持患者的活动能力并减少长期用药。其次，医疗服务模式正向活性化发展。专为居家照护环境设计的安全有效设备正日益受到重视，因为它们有助于缩短住院时间，并符合病患对便利性和隐私性的偏好。第三，从远端监测和设备远端检测到基于应用程式的治疗剂量调整和依从性工具，数位化增强技术正成为影响临床疗效和医疗保险报销的关键因素。

同时，监管管道和证据要求也在不断演变，更加强调实际应用效果和上市后筹资策略对于产品持续供应至关重要，而医疗器材製造商与服务供应商之间的策略伙伴关係则正在加快产品从研发到临床应用的进程。面对这些变化，企业必须采取整合策略，将临床检验、监管规划和商业执行有机结合起来，以保持竞争力并与时俱进。

2025年累积关税以及由此导致的供应链和采购调整，已经重塑了成本结构、供应商策略和产品上市时间表。

2025 年实施的累积关税加剧了整个医疗技术供应链的成本压力和采购复杂性，给製造商和下游供应商带来了营运压力。

对关键进口零件和组件征收的关税增加了依赖国际采购电子模组、精密元件和特殊聚合物的设备製造商的到岸成本。为此，许多公司立即采取了成本缓解措施，例如重新谈判供应商合约、增加库存缓衝以及加快对受影响较小国家的替代供应商进行资格认证。虽然这些短期应对措施有助于稳定生产，但也导致利润率下降，在某些情况下，也延长了检验週期，从而推迟了产品上市。

在此期间，采购团队和医疗系统调整了采购策略，优先选择供应链多元化且拥有本地生产基础的供应商，减轻了贸易动态的影响。在整个生态系统中，关税促使各方对垂直整合方案进行策略性评估，并更重视产品开发中面向供应链的弹性设计。重要的是，这些变更也加强了商业部门和监管部门之间的合作，以确保组件替代符合设备安全性和验证要求。展望未来，那些将关税风险评估纳入早期产品设计并保持灵活供应商网路的机构，将更有能力应对类似的政策变化，并减少营运中断。

将设备类型、临床用途、分销管道、终端用户治疗环境和购买方式与商业化选择联繫起来的全面细分洞察

细分市场洞察揭示了临床需求、技术契合度和商业性管道在设备类型、应用、分销管道、最终用户和购买方式等方面的交集。依设备类型划分，市场涵盖镇痛输注帮浦、电刺激设备、磁疗设备和射频消融术设备，并进一步细分为输注系统（鞘内输注帮浦和病人自控式止痛帮浦）、电刺激技术（微电流治疗电刺激设备、神经肌肉电刺激和经皮神经电刺激）以及射频消融术方式（双极电波消融方式和脉衝射频消融）。这些区分至关重要，因为它们直接关係到手术基础设施要求、临床医生培训需求和报销说明，从而为商业化策略提供基础。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 推出一款配备人工智慧驱动的个人化疼痛通讯协定的可穿戴式TENS设备
  • 数位疼痛管理医疗设备的监管核准环境正在改变。
  • 生物感测器可穿戴设备的整合实现了对疼痛生物标记的即时监测。
  • 非侵入式神经调节头戴装置在缓解慢性偏头痛的兴起
  • 扩展远端医疗平台以支援远距疼痛治疗设备管理
  • 家用冷光照光治疗设备作为一种减少鸦片类药物用量的止痛方法的出现

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 按设备类型分類的疼痛管理设备市场

  • 止痛药输注泵
    • 脊髓内泵
    • 患者自控镇痛泵
  • 电刺激设备
    • 微电流治疗电刺激装置
    • 神经肌肉电刺激
    • 经皮电神经刺激
  • 磁疗设备
  • 射频消融术装置
    • 双极射频消融
    • 单极射频消融
    • 脉衝射频消融术

第九章 疼痛管理设备市场：依应用领域划分

  • 癌症疼痛管理
  • 月经疼痛管理
  • 肌肉骨骼疼痛管理
    • 关节炎疼痛
    • 腰痛
  • 神经病变疼痛管理
  • 术后疼痛管理
    • 急性术后疼痛
    • 慢性术后疼痛

第十章 按分销管道分類的疼痛管理设备市场

  • 离线
  • 在线的

第十一章 按最终用户分類的疼痛管理设备市场

  • 居家照护
    • 慢性病居家照护
    • 术后居家照护
  • 医院和诊所
    • 一般诊所
    • 疼痛诊所
  • 长期照护中心
    • 安宁疗护
    • 护理机构

第十二章 疼痛管理设备市场：依购买类型划分

  • 非处方药
  • 处方药

第十三章 疼痛管理设备市场：依地区划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 按组别分類的疼痛管理设备市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国疼痛管理设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Abbott Laboratories
    • AVACEN, Inc.
    • Avanos Medical, Inc.
    • B. Braun SE
    • BioElectronics Corporation
    • Boston Scientific Corporation
    • CEFALY Technology
    • Enovis Corporation
    • Healthmate International, LLC
    • HMS Medical Systems
    • ICU Medical, Inc.
    • iTENS, LLC
    • Johari Digital
    • Kimberly-Clark Corporation
    • Medtronic PLC
    • Multi Radiance Medical, Inc.
    • NeuroMetrix, Inc.
    • Nevro Corp.
    • OMRON Healthcare, Inc.
    • Oska Wellness
    • Pain Care Labs
    • Pain Management Technologies, Inc.
    • Pfizer, Inc.
    • Sanofi SA
    • Stryker Corporation
    • Ultracare Pro by Zealmax Innovations Pvt. Ltd.
    • Zynex, Inc.
Product Code: MRR-ED54C46E8320

The Pain Management Devices Market is projected to grow by USD 7.32 billion at a CAGR of 9.06% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.65 billion
Estimated Year [2025] USD 3.97 billion
Forecast Year [2032] USD 7.32 billion
CAGR (%) 9.06%

A clear and strategic orientation that frames the evolving clinical, commercial, and regulatory environment shaping modern pain management device strategies

This executive summary opens with an evidence-based orientation to the complex, rapidly evolving field of pain management devices, articulating the purpose of the report and the value it provides to clinical, commercial, and policy stakeholders.

The introduction establishes context by highlighting converging forces that influence product development and adoption, including the shift toward non-opioid therapeutic strategies, the rise of outpatient and home-based care models, and growing integration of digital health capabilities with device platforms. These dynamics are reshaping clinical pathways and decision-making criteria for physicians, hospital administrators, and payers alike. The narrative underscores the need for device makers and service providers to reexamine product portfolios, go-to-market models, and collaborative partnerships in light of clinical preference changes and patient-centric care trends.

Additionally, this section outlines the report's analytical framework and the types of evidence synthesized, clarifying how regulatory considerations, reimbursement pressures, supply chain resilience, and technological convergence inform the insights that follow. By framing key questions around safety, efficacy, usability, and integration, the introduction sets up a pragmatic lens through which readers can interpret subsequent sections and apply findings to product strategy, market entry planning, and investment assessment.

How clinical preference shifts, decentralization of care, digital integration, and evolving regulatory expectations are redefining product and commercial strategies in pain management devices

The landscape of pain management devices is undergoing several transformative shifts that alter clinical workflows, product lifecycles, and commercial priorities.

First, there is a pronounced move toward neuromodulation and minimally invasive interventions as clinicians seek durable, non-pharmacologic modalities to reduce reliance on systemic analgesics. This trend has elevated research into electrical stimulation, radiofrequency techniques, and magnetic therapies that target specific pain pathways while preserving patient mobility and reducing long-term medication exposure. Second, care delivery is decentralizing; devices designed for safe, effective use in home care settings are gaining strategic importance because they support shorter hospital stays and resonate with patient preferences for convenience and privacy. Third, digital augmentation-ranging from remote monitoring and device telemetry to app-based therapy titration and adherence tools-is increasingly a differentiator for both clinical outcomes and payer reimbursement conversations.

Concurrently, regulatory pathways and evidence requirements are evolving to emphasize real-world performance and post-market surveillance, prompting manufacturers to invest in data generation capabilities. Supply chain resilience and component sourcing strategies have become central to product continuity, while strategic partnerships between device companies and service providers accelerate route-to-patient timelines. Together, these shifts require organizations to adopt integrated strategies that align clinical validation, regulatory planning, and commercial execution to remain competitive and relevant.

The 2025 cumulative tariff measures and the resultant supply chain and procurement adjustments that reshaped cost profiles, supplier strategies, and product launch timetables

Cumulative tariff actions implemented in 2025 have introduced amplified cost pressures and procurement complexities across medtech supply chains, creating operational stress for manufacturers and downstream providers.

Tariffs applied to key imported components and subassemblies have increased landed costs for device manufacturers that rely on international sourcing of electronic modules, precision components, and specialized polymers. In response, many organizations undertook near-term cost mitigation measures such as renegotiating supplier contracts, increasing inventory buffers, and accelerating efforts to qualify alternate suppliers from less-impacted jurisdictions. These short-term responses helped stabilize production but introduced margin compression and, in some cases, delayed product launches due to extended validation timelines.

Over the same period, procurement teams and health systems adjusted purchasing strategies, prioritizing suppliers with diversified supply chains or local manufacturing footprints to reduce exposure to trade dynamics. Across the ecosystem, the tariffs catalyzed strategic review of vertical integration options and increased emphasis on design-for-supply resilience during product development. Importantly, these changes also intensified collaboration between commercial and regulatory functions to ensure that component substitutions complied with device safety and validation requirements. Looking ahead, organizations that integrate tariff risk assessment into early-stage product design and maintain flexible supplier networks are positioned to navigate similar policy shifts with less operational disruption.

Comprehensive segmentation insights that connect device types, clinical applications, distribution routes, end-user care settings, and purchase modes to commercialization choices

Segmentation insights illuminate where clinical need, technology fit, and commercial pathways intersect across device type, application, distribution channel, end user, and purchase mode. Based on device type, the market spans analgesic infusion pumps, electrical stimulation devices, magnetic therapy devices, and radiofrequency ablation devices, with further granularity that differentiates intrathecal pumps and patient-controlled analgesia pumps within infusion systems, and microcurrent therapy E-Stim devices, neuromuscular electrical stimulation, and transcutaneous electrical nerve stimulation within electrical stimulation technologies; radiofrequency ablation modalities are further distinguished by bipolar, monopolar, and pulsed RF approaches. These distinctions are material because they align directly with procedural infrastructure requirements, clinician training needs, and reimbursement descriptors, thereby informing commercialization strategy.

Based on application, devices are deployed across cancer pain management, menstrual pain management, musculoskeletal pain management, neuropathic pain management, and post-operative pain management, where musculoskeletal care subdivides into arthritis pain and back pain and post-operative care differentiates between acute post-surgical pain and chronic surgical pain. Clinical utilization patterns across these applications shape product feature priorities, patient selection criteria, and evidence generation plans. Based on distribution channel, end users and purchase pathways vary between offline channels, such as hospitals and clinics, and online channels that serve direct-to-patient models and digital platforms; this split dictates marketing, service, and logistics approaches. Based on end user, the landscape includes home care settings, hospitals and clinics, and long-term care centers, with home care further segmented into chronic illness home care and post-surgery home care, hospitals and clinics differentiating neutral clinics from specialized pain clinics, and long-term care centers including hospices and nursing homes-each setting requires distinct usability, training, and maintenance considerations. Based on mode of purchase, the dichotomy of over-the-counter and prescription-based acquisition defines regulatory pathways, labeling, and clinician involvement in therapy initiation. Together, these segmentation layers provide a practical framework for prioritizing product development, channel strategies, and clinical evidence plans to match each distinct use case and buyer persona.

Distinct regional dynamics and operational priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine market access and commercialization tactics

Regional dynamics influence clinical practice patterns, reimbursement frameworks, and supply chain logistics, creating important implications for product prioritization and market entry approaches. In the Americas, healthcare systems are characterized by a mix of private and public payers, with a strong emphasis on outcomes and evidence-based adoption; this environment rewards devices that deliver demonstrable clinical differentiation and cost-effectiveness while enabling partnerships with integrated delivery networks. In Europe, Middle East & Africa, diverse regulatory regimes and varying reimbursement pathways require tailored regulatory strategies and local clinical validation, and the geopolitical landscape shapes sourcing decisions and deployment timelines for manufacturers of implantable and high-cost therapeutic devices.

Asia-Pacific features heterogeneous markets with rapidly growing demand for outpatient and home-based solutions, rising adoption of digital health tools, and substantial local manufacturing capacity that can support cost-competitive sourcing and faster time-to-market in regional hubs. Across all regions, regional supply chain resilience and the ability to navigate local clinical guidelines and payer expectations remain critical, but the operational priorities differ: the Americas often prioritize rigorous clinical outcomes and integrated care partnerships, Europe, Middle East & Africa call for regulatory navigation and local stakeholder engagement, and Asia-Pacific emphasizes scalability, affordability, and digital-enabled care delivery. Recognizing these contrasts is essential for tailoring market access strategies and regional investment plans.

How established manufacturers, neuromodulation specialists, and software-driven innovators are shaping competitive advantage through clinical evidence, partnerships, and scalable manufacturing

Competitive dynamics in pain management devices reflect a blend of established medical device manufacturers, specialized neuromodulation innovators, and emerging digital therapeutics firms that emphasize software-enabled therapeutic management. Leading organizations tend to combine clinical trial investment with robust post-market evidence collection and strong clinician engagement programs to build trust among prescribers and purchasing groups. At the same time, niche players and start-ups drive rapid innovation in areas such as minimally invasive radiofrequency ablation techniques, wearable electrical stimulation modalities, and connected infusion pump solutions that support remote titration and adherence monitoring.

Manufacturers that pair hardware expertise with software capabilities and data analytics gain a practical advantage in delivering outcome-tracking and reimbursement-ready evidence. Contract manufacturers and component suppliers play a pivotal role in accelerating time-to-market, particularly for companies seeking to optimize manufacturing capacity without large capital expenditures. Strategic partnerships between device firms and digital health service providers are increasingly common, enabling bundled solutions that integrate therapy delivery, remote monitoring, and patient engagement. Investors and acquirers are attentive to organizations demonstrating regulatory maturity, scalable manufacturing, and credible clinical evidence pathways, while service providers that can support post-market surveillance and real-world data capture become indispensable collaborators in commercialization strategies.

Actionable strategic moves for device makers to align design, evidence, supply chain, and commercial models with decentralized care and payer expectations

Industry leaders seeking to maintain or build market leadership should adopt integrated strategies that align product design, clinical evidence generation, and commercial execution to the realities of decentralized care and payer scrutiny. Begin by embedding supply chain risk assessment and component sourcing flexibility into early-stage design decisions so that product availability is less sensitive to policy shifts and tariff volatility. Simultaneously, prioritize modular product architectures and software-first designs that enable rapid iteration, remote updates, and the addition of value-added digital services that support adherence and outcomes tracking.

Invest in pragmatic evidence generation that combines focused randomized studies with real-world data collection to demonstrate clinical benefit across prioritized applications, such as musculoskeletal and post-operative pain, and to support reimbursement discussions with payers. Strengthen commercial relationships by tailoring go-to-market models to the distribution channel and end-user profile, distinguishing strategies for home care, outpatient clinics, and specialized pain centers. Finally, pursue partnerships with contract manufacturers, specialty suppliers, and digital health firms to accelerate time-to-market while preserving capital efficiency. Taken together, these actions help firms reduce time-to-adoption, mitigate operational risk, and secure a defensible position in a market that increasingly values integrated clinical and digital solutions.

A rigorous, multi-source research approach combining expert interviews, clinical and regulatory analysis, and supply chain mapping to ensure validated and actionable insights

The research methodology underpinning this analysis integrates primary qualitative interviews, document and literature synthesis, regulatory and clinical trial review, and supply chain mapping to ensure robust, triangulated insights. Primary inputs include structured interviews with clinicians across specialties that manage pain, procurement leaders within hospitals and integrated delivery networks, product development leaders at device companies, and supply chain and regulatory specialists. These conversations were designed to capture frontline perspectives on usability, clinical acceptance, and procurement criteria.

Secondary investigation incorporated peer-reviewed clinical literature, regulatory filings, patent landscapes, and publicly available clinical trial registries to assess safety profiles, procedural adoption, and evidence maturity; cross-referencing these sources ensured consistency with practitioner-reported trends. Supply chain analysis examined component sourcing, manufacturing footprints, and logistics vulnerabilities to contextualize tariff impacts and procurement responses. Finally, findings were subjected to iterative validation through expert review panels to confirm interpretive accuracy, clarify ambiguous patterns, and refine practical recommendations for stakeholders seeking to align product strategy with evolving clinical and commercial conditions.

Synthesis of strategic imperatives emphasizing agility, evidence integration, and partnership-driven commercialization in the evolving pain management device market

In conclusion, the pain management device landscape is entering a phase characterized by purposeful innovation, decentralization of care, and greater integration of digital capabilities with therapeutic hardware. These forces are driving differentiation around usability, evidence generation, and service-enabled offerings that extend beyond the device itself. Organizations that respond by aligning early-stage product design with supply chain resilience, by integrating data collection into clinical workflows, and by tailoring commercialization strategies to specific clinical applications and end-user settings will be better positioned to capture sustainable value.

Moreover, the interplay of trade policy, reimbursement complexity, and clinician preference means that organizational agility-expressed through flexible supplier relationships, modular product development, and adaptive regulatory strategies-will be a defining characteristic of successful companies. The strategic path forward emphasizes partnerships, digital integration, and pragmatic evidence generation as core competencies. Firms that cultivate these capabilities can better meet clinician needs, improve patient outcomes, and create compelling value propositions for payers and health systems alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of wearable TENS devices with AI-driven personalized pain protocols
  • 5.2. Regulatory approval landscape evolving for digital pain management health devices
  • 5.3. Integration of biosensor wearables enabling real-time monitoring of pain biomarkers
  • 5.4. Rise of non-invasive neuromodulation headsets for chronic migraine relief therapies
  • 5.5. Expansion of telehealth platforms supporting remote pain therapy device management
  • 5.6. Emergence of at-home cold laser therapy devices as opioid-sparing pain solutions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pain Management Devices Market, by Device Type

  • 8.1. Analgesic Infusion Pumps
    • 8.1.1. Intrathecal Pumps
    • 8.1.2. Patient-Controlled Analgesia Pumps
  • 8.2. Electrical Stimulation Devices
    • 8.2.1. Microcurrent Therapy E-Stim Devices
    • 8.2.2. Neuromuscular Electrical Stimulation
    • 8.2.3. Transcutaneous Electrical Nerve Stimulation
  • 8.3. Magnetic Therapy Devices
  • 8.4. Radiofrequency Ablation Devices
    • 8.4.1. Bipolar RF Ablation
    • 8.4.2. Monopolar RF Ablation
    • 8.4.3. Pulsed RF Ablation

9. Pain Management Devices Market, by Application

  • 9.1. Cancer Pain Management
  • 9.2. Menstrual Pain Management
  • 9.3. Musculoskeletal Pain Management
    • 9.3.1. Arthritis Pain
    • 9.3.2. Back Pain
  • 9.4. Neuropathic Pain Management
  • 9.5. Post-Operative Pain Management
    • 9.5.1. Acute Post-Surgical Pain
    • 9.5.2. Chronic Surgical Pain

10. Pain Management Devices Market, by Distribution Channel

  • 10.1. Offline
  • 10.2. Online

11. Pain Management Devices Market, by End User

  • 11.1. Home Care Settings
    • 11.1.1. Chronic Illness Home Care
    • 11.1.2. Post-Surgery Home Care
  • 11.2. Hospitals And Clinics
    • 11.2.1. Neutral Clinics
    • 11.2.2. Pain Clinics
  • 11.3. Long-Term Care Centers
    • 11.3.1. Hospices
    • 11.3.2. Nursing Homes

12. Pain Management Devices Market, by Mode of Purchase

  • 12.1. Over-the-counter
  • 12.2. Prescription-based

13. Pain Management Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pain Management Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pain Management Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. AVACEN, Inc.
    • 16.3.3. Avanos Medical, Inc.
    • 16.3.4. B. Braun SE
    • 16.3.5. BioElectronics Corporation
    • 16.3.6. Boston Scientific Corporation
    • 16.3.7. CEFALY Technology
    • 16.3.8. Enovis Corporation
    • 16.3.9. Healthmate International, LLC
    • 16.3.10. HMS Medical Systems
    • 16.3.11. ICU Medical, Inc.
    • 16.3.12. iTENS, LLC
    • 16.3.13. Johari Digital
    • 16.3.14. Kimberly-Clark Corporation
    • 16.3.15. Medtronic PLC
    • 16.3.16. Multi Radiance Medical, Inc.
    • 16.3.17. NeuroMetrix, Inc.
    • 16.3.18. Nevro Corp.
    • 16.3.19. OMRON Healthcare, Inc.
    • 16.3.20. Oska Wellness
    • 16.3.21. Pain Care Labs
    • 16.3.22. Pain Management Technologies, Inc.
    • 16.3.23. Pfizer, Inc.
    • 16.3.24. Sanofi S.A.
    • 16.3.25. Stryker Corporation
    • 16.3.26. Ultracare Pro by Zealmax Innovations Pvt. Ltd.
    • 16.3.27. Zynex, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. PAIN MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. PAIN MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PAIN MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2025-2032 (USD MILLION)

TABLE 29